BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25631232)

  • 1. Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability.
    Terzuoli E; Monti M; Vellecco V; Bucci M; Cirino G; Ziche M; Morbidelli L
    Br J Pharmacol; 2015 Jun; 172(12):2961-73. PubMed ID: 25631232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H
    Monti M; Terzuoli E; Ziche M; Morbidelli L
    Pharmacol Res; 2016 Nov; 113(Pt A):426-437. PubMed ID: 27650753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition.
    Bucci M; Vellecco V; Cantalupo A; Brancaleone V; Zhou Z; Evangelista S; Calderone V; Papapetropoulos A; Cirino G
    Cardiovasc Res; 2014 Apr; 102(1):138-47. PubMed ID: 24501330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis.
    Monti M; Terzuoli E; Ziche M; Morbidelli L
    Pharmacol Res; 2013 Oct; 76():171-81. PubMed ID: 23965518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium.
    Donnini S; Solito R; Giachetti A; Granger HJ; Ziche M; Morbidelli L
    J Pharmacol Exp Ther; 2006 Nov; 319(2):515-22. PubMed ID: 16868034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a functional vasodilatatory role for hydrogen sulphide in the human cutaneous microvasculature.
    Kutz JL; Greaney JL; Santhanam L; Alexander LM
    J Physiol; 2015 May; 593(9):2121-9. PubMed ID: 25639684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk.
    Donnini S; Terzuoli E; Ziche M; Morbidelli L
    J Pharmacol Exp Ther; 2010 Mar; 332(3):776-84. PubMed ID: 19959747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells.
    Altaany Z; Yang G; Wang R
    J Cell Mol Med; 2013 Jul; 17(7):879-88. PubMed ID: 23742697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo.
    Umaru B; Pyriochou A; Kotsikoris V; Papapetropoulos A; Topouzis S
    J Pharmacol Exp Ther; 2015 Jul; 354(1):79-87. PubMed ID: 25977483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Angiogenic Activity and Molecular Mechanisms of ZYZ-803, a Slow-Releasing Hydrogen Sulfide-Nitric Oxide Hybrid Molecule.
    Hu Q; Wu D; Ma F; Yang S; Tan B; Xin H; Gu X; Chen X; Chen S; Mao Y; Zhu YZ
    Antioxid Redox Signal; 2016 Sep; 25(8):498-514. PubMed ID: 27174595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of thiosulfate in hydrogen sulfide-dependent redox signaling in endothelial cells.
    Leskova A; Pardue S; Glawe JD; Kevil CG; Shen X
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H256-H264. PubMed ID: 28550177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
    Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP
    Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis.
    Macabrey D; Deslarzes-Dubuis C; Longchamp A; Lambelet M; Ozaki CK; Corpataux JM; Allagnat F; Déglise S
    Eur J Vasc Endovasc Surg; 2022 Feb; 63(2):336-346. PubMed ID: 34916111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DR1 activation promotes vascular smooth muscle cell apoptosis via up-regulation of CSE/H
    Wen X; Xi Y; Zhang Y; Jiao L; Shi S; Bai S; Sun F; Chang G; Wu R; Hao J; Li H
    FASEB J; 2022 Jan; 36(1):e22070. PubMed ID: 34859931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis.
    Marampon F; Gravina GL; Scarsella L; Festuccia C; Lovat F; Ciccarelli C; Zani BM; Polidoro L; Grassi D; Desideri G; Evangelista S; Ferri C
    J Hypertens; 2013 Oct; 31(10):1972-83. PubMed ID: 23868084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the cystathionine γ lyase/hydrogen sulfide pathway in human melanoma progression.
    Panza E; De Cicco P; Armogida C; Scognamiglio G; Gigantino V; Botti G; Germano D; Napolitano M; Papapetropoulos A; Bucci M; Cirino G; Ianaro A
    Pigment Cell Melanoma Res; 2015 Jan; 28(1):61-72. PubMed ID: 25205294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen sulphide and angiogenesis: mechanisms and applications.
    Szabó C; Papapetropoulos A
    Br J Pharmacol; 2011 Oct; 164(3):853-65. PubMed ID: 21198548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H2S contributes to the hepatic arterial buffer response and mediates vasorelaxation of the hepatic artery via activation of K(ATP) channels.
    Siebert N; Cantré D; Eipel C; Vollmar B
    Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1266-73. PubMed ID: 18974309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of angiogenesis: role of hydrogen sulphide.
    Wang MJ; Cai WJ; Zhu YC
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):764-71. PubMed ID: 20148917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.
    Sargent CA; Sleph PG; Dzwonczyk S; Smith MA; Normandin D; Antonaccio MJ; Grover GJ
    J Pharmacol Exp Ther; 1993 May; 265(2):609-18. PubMed ID: 8496812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.